APA (7th ed.) Citation

Niño‐Ramírez, J. E., Alcoceba, M., Gutiérrez‐Zufiaurre, M. N., Marcos, M., Gil‐Etayo, F. J., Bartol‐Sánchez, M. R., . . . Boix, F. (2024). Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study. HLA: Immune Response Genetics, 104(2), 1. https://doi.org/10.1111/tan.15640

Chicago Style (17th ed.) Citation

Niño‐Ramírez, J. E., et al. "Killer‐cell Immunoglobulin‐like Receptor Polymorphism Is Associated with COVID‐19 Outcome: Results of a Pilot Observational Study." HLA: Immune Response Genetics 104, no. 2 (2024): 1. https://doi.org/10.1111/tan.15640.

MLA (9th ed.) Citation

Niño‐Ramírez, J. E., et al. "Killer‐cell Immunoglobulin‐like Receptor Polymorphism Is Associated with COVID‐19 Outcome: Results of a Pilot Observational Study." HLA: Immune Response Genetics, vol. 104, no. 2, 2024, p. 1, https://doi.org/10.1111/tan.15640.